Features

Commercial Infographic | HCPs must deal with communication breakdown

Infographic | HCPs must deal with communication breakdown

Drugmakers are proud of the patient service programs they've developed. Yet there remains a disconnect in the way information is communicated to HCPs.

Features Experts weigh in: How will health technology advance in 2018?

Experts weigh in: How will health technology advance in 2018?

Innovation-minded executives share their thoughts and predictions for the year ahead.

Pipeline The 2018 pipeline report: Aspiring assets to keep an eye on

The 2018 pipeline report: Aspiring assets to keep an eye on

The most promising products in pharma's pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.

Sponsored Speaker bureaus must change to stay relevant, experts say

Speaker bureaus must change to stay relevant, experts say

To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.

Commercial How Aubagio became the most switched-to oral MS drug

How Aubagio became the most switched-to oral MS drug

Second to market and dismissed as inferior to the competition, Sanofi's Aubagio seemed destined for lower-tier status. Here's how it overcame the initial obstacles and, five years later, become a potent market force

Careers

The MM&M 2017 Career and Salary Survey Premium Edition

This year's offering includes access to the most current and in-depth data on salary and compensation trends, job satisfaction, recruitment and retention tactics, and more.

Features Read the October 2017 digital edition

Read the October 2017 digital edition

Read the October 2017 issue in its entirety, including our Career and Salary Survey.

Campaigns Medical journal ad spend in H1 2017: All the data in one place

Medical journal ad spend in H1 2017: All the data in one place

The top three most advertised brands were GlaxoSmithKline's Breo Ellipta, Eli Lilly's Trulicity, and Boehringer Ingelheim's Jardiance.

Careers The professional paths of 8 pharma execs

The professional paths of 8 pharma execs

The successes of these pharma execs show that there's no one path to professional bliss.

Sponsored AbelsonTaylor's Jay Carter on the key to retaining top talent

AbelsonTaylor's Jay Carter on the key to retaining top talent

Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.